OPTI Share Price Performance
CA$0.40
0.18 (79.55%)
Price CA$0.40
Share PriceCA$0.40
Is Optimi Health (CSE:OPTI) Using Too Much Debt?
Jun 24
Optimi Health Corp. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
OPTI Community Narratives
There are no narratives available yet.
Optimi Health Corp. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.042
- Gross Margin
- -6.95%
- Net Profit Margin
- -745.34%
- Debt/Equity Ratio
- 36.8%
Optimi Health Corp. Competitors
Snowflake Analysis
About OPTI
- Founded
- 2020
- Employees
- n/a
- CEO
- WebsiteView website
Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of manufacturing of drug products. It sells its products through Amazon marketplace and distributors/brokers, as well as online. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Canadian Market Performance
- 7 Days: 1.6%
- 3 Months: 10.7%
- 1 Year: 22.2%
- Year to Date: 20.2%
The market is up 1.6% over the last week, with the Materials sector leading the way, up 3.0%. As for the past 12 months, the market is up 22%. Looking forward, earnings are forecast to grow by 11% annually. Market details ›